שורה 1: |
שורה 1: |
| <div style="direction:ltr"> | | <div style="direction:ltr"> |
| | | |
− | Dose Response Curve (DRC): | + | Dose Response Curve (DRC): |
| | | |
− | When we give a dose of drug (DOG),
| + | When we give a dose of drug (DOG), |
− | form 1 molecule up to any higher amount,
| + | form 1 molecule up to any higher amount, |
− | there is the Maximal Effect Dose (MED),
| + | there is the Maximal Effect Dose (MED), |
− | by means of treatment (changing a current state for a better one).
| + | by means of treatment (changing a current state for a better one). |
− | Thus, we also have dosages which are Non Maximal Effect Dosages (NMEDs).
| + | Thus, we also have dosages which are Non Maximal Effect Dosages (NMEDs). |
| | | |
− | The ratio between any NMED to the MED, is called the Margin Of Safety (MOS).
| + | The ratio between any NMED to the MED, is called the Margin Of Safety (MOS). |
− | There is an accepted formula to calculate MOS (to translate it to a dose).
| + | There is an accepted formula to calculate MOS (to translate it to a dose). |
− | MOS translated into a dosage is called a Terapheutic Index (TI).
| + | MOS translated into a dosage is called a Terapheutic Index (TI). |
− | To calculate TI, two different dosages are given to one group of examinees (in different, isolated periods).
| + | To calculate TI, two different dosages are given to one group of examinees (in different, isolated periods). |
− | The one which helps in at least 50% of the cases is the TI, the desired dosage.
| + | The one which helps in at least 50% of the cases is the TI, the desired dosage. |
| | | |
− | More dosage.
| + | More dosage. |
− | More risk.
| + | More risk. |
− | Due to law of mass action.
| + | Due to law of mass action. |
| | | |
| </div> | | </div> |